Division of Cardiovascular Diseases

clinical trials

Clinical Trials

Trial Title Condition Location
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography Cardiac allograft vasculopathy (CAV) Minnesota
Assessmet of Patients With PAH Right Ventricular Volume Pulmonary Arterial Hypertension Minnesota
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study Atrial Fibrillation Minnesota
Arizona
B-type Natriuretic Peptide (BNP) in Human Hypertension Hypertension Minnesota
Biomarkers in Aortic Stenosis - B.A.S.S. Aortic stenosis Florida
Bone Marrow Aspirate Concentrate (BMAC) for Treatment of Critical Limb Ischemia (CLI) Ischemic Cardiomyopathy Arizona
Peripheral Arterial Disease
Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients? Hypertension Arizona
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure Heart Failure, Congestive Minnesota
Heart Failure
Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging Heart Failure Minnesota
Congestive heart failure (CHF)
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Atrial Fibrillation Minnesota
CD-NP in Subjects With Stable Chronic Heart Failure Heart Failure Minnesota
CentriMag RVAS U.S. Post-approval Study Protocol Heart Failure Arizona
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass Cardiopulmonary bypass Arizona
Chronic Administration of Subcutaneous Brain Natriuretic Peptide (SQ BNP) on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading Cardiorenal Syndrome Minnesota
Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study Muscular ventricular septal defects Minnesota
Correlation of Endothelial Function and Early Coronary Artery Disease in Humans Coronary Artery Disease Minnesota
Atherosclerosis
Endothelial Dysfunction
Heart Disease
Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function Renal Dysfunction Minnesota
<<Previous 1  2  3  4  Next >>
Display All Pages


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.